Ki67表达及EGFR突变对I期肺腺癌患者 术后复发转移风险的相关分析.
- Published in:
- Chinese Journal of Lung Cancer, 2022, v. 25, n. 12, p. 852, doi. 10.3779/j.issn.1009-3419.2022.101.55
- By:
- Publication type:
- Article
Works matching IS 10093419 AND DT 2022 AND VI 25 AND IP 12
Results: 8
1
2
青年型非小细胞肺癌治疗研究进展.
- Published in:
- Chinese Journal of Lung Cancer, 2022, v. 25, n. 12, p. 888, doi. 10.3779/j.issn.1009-3419.2022.102.48
- By:
- Publication type:
- Article
3
合并MET基因变异的非小细胞肺癌治疗 研究进展.
- Published in:
- Chinese Journal of Lung Cancer, 2022, v. 25, n. 12, p. 877, doi. 10.3779/j.issn.1009-3419.2022.101.54
- By:
- Publication type:
- Article
4
组织驻留记忆T细胞在肺癌中的研究进展.
- Published in:
- Chinese Journal of Lung Cancer, 2022, v. 25, n. 12, p. 862, doi. 10.3779/j.issn.1009-3419.2022.102.49
- By:
- Publication type:
- Article
5
磨玻璃结节型肺癌胸膜改变与脏层胸膜侵犯 的相关性研究进展.
- Published in:
- Chinese Journal of Lung Cancer, 2022, v. 25, n. 12, p. 895, doi. 10.3779/j.issn.1009-3419.2022.102.50
- By:
- Publication type:
- Article
6
奥希替尼联合贝伐珠单抗在获得性EGFR T790M突变晚期非小细胞肺癌的疗效分析.
- Published in:
- Chinese Journal of Lung Cancer, 2022, v. 25, n. 12, p. 843, doi. 10.3779/j.issn.1009-3419.2022.101.56
- By:
- Publication type:
- Article
7
外泌体miR-10b通过调控巨噬细胞M2极化 促进肺腺癌A549细胞的侵袭和上皮间质转化.
- Published in:
- Chinese Journal of Lung Cancer, 2022, v. 25, n. 12, p. 835, doi. 10.3779/j.issn.1009-3419.2022.101.50
- By:
- Publication type:
- Article
8
非小细胞肺癌N2亚分期研究进展.
- Published in:
- Chinese Journal of Lung Cancer, 2022, v. 25, n. 12, p. 870, doi. 10.3779/j.issn.1009-3419.2022.101.53
- By:
- Publication type:
- Article